Vascular endothelial cell dysfunction and Alzheimer′s disease

被引:0
|
作者
JIANG Xinhai [1 ]
ZHANG Lan [1 ]
机构
[1] Department of Pharmacy, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing Engineering Research Center for Nervous System Drugs, Beijing Institute for Brain Disorders, Key Laboratory for Neurode
关键词
D O I
暂无
中图分类号
R749.16 [];
学科分类号
100203 ;
摘要
Alzheimer′s disease (AD) is a neurodegenerative disease with complex pathological mechanism characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain. Increasing evidence suggests that vascular dysfunction due to endothelial cell injury may have a pathogenic role in the occurrence and development of AD. Malfunction of the bloodbrain barrier caused by endothelial cell dysfunction is associated with the accumulation of several neurotoxic molecules within brain parenchyma, a reduction in cerebral blood flow, amyloid-β transfer and hypoxia, especially at the early stages of the disease. At the same time, it cannot be ignored that the peripheral arterial vascular endothelial cell dysfunction also seems to be closely related to the risk and the severity of symptoms of AD. Some molecules are thought to be messengers connecting the central and peripheral endothelial cells. Peripheral and central vascular endothelial cells communicate with each other and influence the progression of AD through some common mechanisms. In this review, we provide an appraisal of the endothelial cell dysfunction in cerebral and systemic vasculature, and give the evidence that vascular pathology is inextricably linked to disease onset and progression of AD.
引用
收藏
页码:494 / 495
页数:2
相关论文
共 50 条
  • [41] Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
    Paula Grammas
    Journal of Neuroinflammation, 8
  • [42] Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
    Grammas, Paula
    JOURNAL OF NEUROINFLAMMATION, 2011, 8
  • [43] Insights into T-cell dysfunction in Alzheimer's disease
    Dai, Linbin
    Shen, Yong
    AGING CELL, 2021, 20 (12)
  • [44] Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease
    Eckert, A
    Keil, U
    Marques, CA
    Bonert, A
    Frey, C
    Schüssel, K
    Müller, WE
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (08) : 1627 - 1634
  • [45] Endothelial dysfunction and vascular disease in later life
    Virdis, A.
    Ghiadoni, L.
    Giannarelli, C.
    Taddei, S.
    MATURITAS, 2010, 67 (01) : 20 - 24
  • [46] Endothelial Dysfunction and Inflammatory Markers of Vascular Disease
    Balta, Sevket
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (03) : 243 - 249
  • [47] Oxidative stress and endothelial dysfunction in vascular disease
    Pennathur S.
    Heinecke J.W.
    Current Diabetes Reports, 2007, 7 (4) : 257 - 264
  • [48] Microvascular endothelial dysfunction in vascular senescence and disease
    Kasal, Daniel A.
    Sena, Viviane
    Huguenin, Grazielle Vilas Boas
    De Lorenzo, Andrea
    Tibirica, Eduardo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 12
  • [49] Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems
    Badimon, Ana
    Torrente, Daniel
    Norris, Erin H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [50] Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease
    Apatiga-Perez, Ricardo
    Soto-Rojas, Luis O.
    Campa-Cordoba, B. Berenice
    Luna-Viramontes, Nabil Itzi
    Cuevas, Elvis
    Villanueva-Fierro, Ignacio
    Ontiveros-Torres, Miguel Angel
    Bravo-Munoz, Marely
    Flores-Rodriguez, Paola
    Garces-Ramirez, Linda
    de la Cruz, Fidel
    Montiel-Sosa, Jose Francisco
    Pacheco-Herrero, Mar
    Luna-Munoz, Jose
    METABOLIC BRAIN DISEASE, 2022, 37 (01) : 39 - 50